Influence of Corticoids on Renal Function in Cardiac Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00879931|
Recruitment Status : Unknown
Verified December 2014 by University Hospital, Ghent.
Recruitment status was: Recruiting
First Posted : April 13, 2009
Last Update Posted : December 5, 2014
Hypothesis: Corticoid treatment in cardiac surgery works renal protective.
Study design: Randomized, double blind trial in which one group of patients will receive methylprednisolone and the other group (control) will receive placebo NaCl 0.9%.
|Condition or disease||Intervention/treatment||Phase|
|Elective Cardiac Surgery||Drug: Methylprednisolone Drug: Placebo||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Influence of Corticoids on Renal Function in Cardiac Surgery|
|Study Start Date :||January 2013|
|Estimated Primary Completion Date :||July 2015|
|Estimated Study Completion Date :||July 2015|
Placebo Comparator: 2
Placebo (NaCl 0.9%)
Placebo (NaCl 0.9%)
- Renal dysfunction and renal failure postoperatively in cardiac surgery [ Time Frame: within 48 hours after cardiac surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00879931
|Contact: Stefaan Bouchez, MDemail@example.com|
|University Hospital Ghent||Recruiting|
|Ghent, Belgium, 9000|
|Contact: Stefaan Bouchez, MD firstname.lastname@example.org|
|Principal Investigator:||Stefaan Bouchez, MD||University Hospital, Ghent|